KNSA: Kiniksa Company Aggregate Debts
Risks are linked to the dependence on the commercial success of orphan drugs under the leadership of Sanjiv Patel. Changes in Kiniksa Pharmaceuticals (KNSA) obligations confirm financial stability, where the 0.00 level reflects the current magnitude of borrowings. Stability is supported by ESG standards in drug manufacturing and the implementation of robotic dosing in laboratories alongside logistics control software for medications.
%3A%20Company%20Debts&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_KNSA_-_Kiniksa-Pharmaceuticals_-_Company-Debts "Aggregate Debt Obligations: Kiniksa Pharmaceuticals Ltd (KNSA) for 07/04/2022 - 10/30/2026 | 👁️GURU.Markets👁️")
Kiniksa (KNSA) - metric breakdowns and financial figures
- share price and consensus valuation forecast:
- market capitalization information:
- balance sheet equity data:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Kiniksa Pharmaceuticals|KNSA - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Kiniksa Pharmaceuticals, Ltd.|KNSA - Company Aggregate Debts|Debts to Net Assets Kiniksa Pharmaceuticals Ltd|KNSA - Company Long-Term Debt|Company Current Liabilities Kiniksa|Quick Liquidity Indicator kiniksa.com
- earnings and valuation multiples information:
General company analysis:KNSA, Kiniksa Corp
Assessing the investment reliability of equity assets requires an analysis of total debt dynamics to eliminate default risk. This indicator aggregates short-term and long-term liabilities, allowing for a comparison of the financial burden against the expansion rates of Kiniksa Pharmaceuticals (KNSA) in the orphan drug sector, which makes changes in the company's liabilities a key tool for monitoring the sustainability of its aggressive growth.
Competitors of Kiniksa Pharmaceuticals
ARGX (argenx BVBA) - Aggregate Debt Obligations|Company Aggregate Debts BNTX (BioNTech SE)|Company Aggregate Debts Abivax Corp ABVX|ADMA - Company Debts|Aggregate Debt Obligations PTGX (Protagonist Therapeutics, Inc.)|Immunovant Corp (IMVT) - Company Debts|Company Total Debt Grifols Biemat|ADPT (Adaptive Biotechnologies) - Company Aggregate Debts|Company Aggregate Debts celldex.com|Company Total Debt AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Aggregate Debt Obligations|Company Aggregate Debts VERA (Vera Pharma)|Company Total Debt Obligations Dianthus Corp (DNTH)|PHVS - Company Debts|AbCellera Biologics Inc (ABCL) - Company Total Debt|Tourmaline Bio (TRML) - Company Debts|Company Total Debt Precigen Inc|Company Total Debt PHAR|Company Aggregate Debts Nektar Corp|Company Debts Upstream Bio Inc (UPB)|zenasbio.com - Company Aggregate Debt|Company Aggregate Debts IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Company Cumulative Debt|KALV - Company Debts|SEPN - Company Aggregate Debts|PVLA: Company Aggregate Debts|SVRA - Company Total Debt Obligations|Company Debts Rigel Pharmaceuticals, Inc.|Company Aggregate Debt ANAB (AnaptysBio Inc)|Company Aggregate Debts ATXS|Company Total Debt Obligations enGene Corp|Company Debts RAPT Therapeutics RAPT|Company Aggregate Debts Aerovate Therapeutics, Inc. JBIO|ACRS - Company Debts|Company Total Debt Obligations Kyverna Therapeutics Inc. KYTX|TLSA: Company Aggregate Debts|Cabaletta Bio Inc (CABA) - Company Aggregate Debts|Company Total Debt VTYX|THTX: Aggregate Debt Obligations|Company Debts Avalo Therapeutics (AVTX)|ELDN: Company Aggregate Indebtedness|Company Aggregate Debts AGEN (Agenus Inc)|Aggregate Debt Obligations CLYM|Zura Bio - Company Aggregate Debts|ATYR - Company Aggregate Debts|adagene.com (ADAG) - Company Debts|Ikena Oncology - Aggregate Debt Obligations|Company Debts Shattuck Labs Inc|Company Total Debt Equillium Bio (EQ)|Company Aggregate Debts CNTB|Company Aggregate Debts immunic-therapeutics.com (IMUX)|Company Aggregate Debts ATRA (Atara Bio)|IFRX - Company Total Debt|X4 Pharma - Company Aggregate Debts|Company Cumulative Debt Adicet Bio|CELU (celularity.com) - Company Total Debt|inmunebio.com (INMB) - Company Aggregate Debts|Company Total Debt BRNS|KZR (Kezar Life Sciences Inc.) - Company Cumulative Indebtedness|Company Aggregate Debts SABS|Company Total Debt Obligations Akari Therapeutics, Plc|Company Aggregate Debts ENLV (Enlivex Therapeutics Ltd.)|QTTB - Company Total Debt|GeoVax - Company Aggregate Debts|EDSA - Company Aggregate Debts|iBio Corp (IBIO) - Company Debts|CARM (Carisma Therapeutics Inc.) - Company Debts|Company Debts XTL Biopharmaceuticals|Bolt Bio (BOLT) - Company Total Debt Obligations|Company Debts HCW Biologics Inc. (HCWB)|Company Aggregate Debts aptevotherapeutics.com (APVO)|Company Debts AIM ImmunoTech Inc. AIM|ADTX: Company Aggregate Debt|GRI - Company Debts|Company Total Debt Obligations xortx.com XRTX|HIND: Company Aggregate Debts|Revelation Biosciences Inc (REVB) - Company Aggregate Debts|Company Debts Indaptus|BiondVax Pharmaceuticals - Company Aggregate Indebtedness|Company Aggregate Debts CALI|AFMD (affimed.com) - Aggregate Debt Obligations|Company Aggregate Debts ALLK (Allakos)|Company Aggregate Debts HOOKIPA Pharma, Inc. HOOK|IGMS - Company Debts|Aggregate Debt Obligations ITOS (iTeos Pharma)|Ocean Biomedical, Inc. (OCEA) - Company Debts|Company Total Debt tcbiopharm.com|THRD (Third Harmonic Bio, Inc.) - Company Aggregate Debts